Conventional trial designs offer limited clinical understanding of cholinesterase-inhibitor treatment effects in Alzheimer disease. (Q53267491)
Jump to navigation
Jump to search
scientific article published in February 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Conventional trial designs offer limited clinical understanding of cholinesterase-inhibitor treatment effects in Alzheimer disease. |
scientific article published in February 2005 |
Statements
Conventional trial designs offer limited clinical understanding of cholinesterase-inhibitor treatment effects in Alzheimer disease. (English)
Annalena Venneri
1 reference
Michael F Shanks
1 February 2005
13
2
170; author reply 170-1